Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 3, 2005, Pages 376-379

  Rahier, J F ^a   Lion, L ^a   Dewit, O ^a   Lambert, Michel ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anti TNF therapy; Crohn's disease; Sweet's syndrome

Indexed keywords

AZATHIOPRINE; BUDENOFALK; CIPROFLOXACIN; COLITOFALK; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE;

ABDOMINAL RADIOGRAPHY; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE EXACERBATION; DRUG DOSE REGIMEN; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; RECTOVAGINAL FISTULA; REMISSION;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DERMATOLOGIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; SWEET'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26944454852     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. RAMBAUD J.-C. Traité de gastro-entérologie. Médecine-Sciences Flammarion, 2000, p. 611-624.
2. TRAVIS S., INNES N., DAVIES M.G., DANESHMEND T., HUGHES S. Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group. Eur. J. Gastroenterol. Hepatol., 1997, 9: 715-20.
3. VON DEN DRIESCH P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J. Am. Acad. Dermatol., 1994, 31: 535-56.
4. FAIN O., MATHIEU E., FETON N., SIBONY M. et al. Intestinal involvement in Sweet's syndrome. J. Am. Acad. Dermatol., 1996, 35: 989-90.
5. MARIE I., BOYER A., HERON F., JOLY P., LEVESQUE H., THOMINE E., COURTOIS H. Focal aseptic osteitis underlying neutrophilic dermatosis. Br. J. Dermatol., 1998, 139: 744-5.
6. CARVALHO P., CORDEL N., COURVILLE P., LELOET X., HERON F., LAURET P., JOLY P. Cutaneous aseptic abscesses, manifestations of neutrophilic diseases. Ann. Dermatol. Venereol., 2001, 128: 641-3.
7. KHAN DURANI B., JAPPE U. Drug- induced Sweet's syndrome in acne caused by different tetracyclines: case report and review of the literature. Br. J. Dermatol., 2002, 147: 558-62.
8. WALTZ K., LONG D., MARKS J.G., BILLINGSLEY E.M. Sweet's syndrome and erythema nodosum: the simultaneous occurrence of 2 reactive dermatoses. Arch. Dermatol., 1999, 135: 62-6.
9. COHEN P.R., HOLDER W.R., RAPINI R. Concurrent Sweet's syndrome and erythema nodosum, a report, world literature review and mechanism of pathogenesis. J. Rheumatol., 1992, 19: 814-820.
10. VANBIERVLIET G., ANTY R., SCHNEIDER S., ARAB K., RAMPAL P., HEBUTERNE X. Sweet syndrome and erythema nodosum associated with Crohn's disease treated by infliximab. Gastroenterol. Clin. Biol., 2002, 26: 295-7.
11. BATY V., ROCCA P., TAVAN D., KOEB M.H., BORY M.R. Vesiculopustular eruption and Crohn's disease. Gastroenterol. Clin. Biol., 2002, 26: 293-5.
12. CRICKX B., RUSZNIEWSKI P., GROSSIN M., BELAÎCH S. Manifestations cutanées d'une maladie de Crohn. Ann. Dermatol. Véné réol., 1986, 113: 949-50.
13. CALLEN J.P. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of "bowel bypass" syndrome and bullous pyoderma gangrenosum. Dermatol. Clin., 1985, 3: 153-63.
14. RAPPAPORT A., SHAKED M., LANDAU M., DOLEV E. Sweet's syndrome in association with Crohn's disease: report of a case and review of the literature. Dis. Colon Rectum, 2001, 44: 1526-9.
15. ACTIS G.C., LAGGET M., CIANCIO A., ROCCA G., TOMASINI C., PUIATTI P., VERME G. Reccurent Sweet's syndrome in reactivated Crohn's disease. J. Clin. Gastroenterol., 1995, 21: 317-319.
16. ANDRE M., AUMAITRE O., MARCHEIX J.C. et al. Aseptic systemic abscesses preceeding diagnosis of Crohn's disease by three years. Dig. Dis. Sci., 1995, 40: 525-27.
17. LY S., BEYLOT-BARRY M., DOUTRE M.S. et al. Syndrome de Sweet associé à une maladie de Crohn. Rev. Med. Intern., 1995, 16: 931-33.
18. CALVO CATALA G., GONZALEZ PEREZ J.A., FEBRER BOSCH I. et al. Sindrome de Sweet. Associado a enfermedad intestinal inflamatoria cronica. An. Med. Intern., 1990, 7: 364-66.
19. BANET D.E., MC CLAVE S.A., CALLEN J.P. Oral metronidazole, an effective treatment for Sweet's syndrome in a patient with associated inflammatory bowel disease. J. Rheumatol., 1994, 21: 1766-68.
20. PODOLSKY D.K. Inflammatory bowel disease. N. Engl. J. Med., 2002, 347: 417-429.
21. PRESENT D.H., RUTGEERTS P., TARGAN S. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med., 1999, 340: 1398-405.
22. FLEICHER M.R., RUBIN S.D., SASSON M., ZLATANIC J., BURNS A., ETZKORN K.P. et al. Infliximab in the treatment of refractory extra intestinal manifestations of Crohn's disease (abstract). Gastroenterology, 2001, 120: A 3147.
23. LJUNG T., STAUN M., GROVE O., FAUSA O., VATN M.H., HELLSTROM P.M. Pyoderma gangrenosum associated with Crohn's disease: effect of TNF alpha blockade with infliximab. Scand. J. Gastroenterol., 2002, 37: 1108-10.
24. GRANGE F., WEISS A.M., POLETTE A., GUILLAUME J.C. Corticosteroid- resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab. Dermatology, 2002, 205: 278-80.
25. TAN M.H., GORDON M., LEBWOHL O., GEORGE J. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn's disease with anti tumor necrosis factor alpha monoclonal antibody. Arch. Dermatol., 2001, 137: 930-3.
26. TRIANTAFILLIDIS J.K., CHERACAKIS P., SKLAVAINA M., APOSTOLOPOULOU K. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum. Scand. J. Gastroenterol., 2002, 37: 863-5.
27. KONRAD A., SEIBOLD F. Response to cutaneous Crohn's disease to infliximab and methotrexate. Dig. Liver Dis., 2003, 35: 351-6.